New weekly gainers - top 3 most hyped stocks on Twitter!

Howdy! We track various indirect companies' metrics to spot the sharp changes which may affect the price of the stocks.  Every week we monitor the number of ticker mentions on Twitter and Reddit and give you interesting insights on the most hyped stocks.

Today's top will consist of 3 companies that have had most of the social buzz over the last week:

1. Aligos Therapeutics Inc. ($ALGS) - a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases.

Last week $ALGS has appointed Bridget Martell, MA, M.D., to the Company’s board of directors and it's got hyped on Twitter. These guys are also attending the conferences and their presentations are lit! Also, we can see from the analysis that they're making moves and getting actively discussed almost every 2 weeks - great statistics!

2. Cyberark Software Ltd ($CYBR) - the company develops, markets, and sales software-based security solutions and services in the United States, Europe, the Middle East, Africa, and internationally.

$CYBR has risen sharply lately on the heels of a strong third-quarter report and by adding 230 new customers on the quarter. Investors need to expect volatility, as evidenced by plenty of ups and downs in share price over the past few years. Thus, when things move in the right direction it can really pay off — as it has since spring, when $CYBR stock nearly doubled from about $110 to current levels around $200 per share.

Also, just an interesting oversight - the $CYBR are getting almost 2x more traffic to the website during the last months compared as they usually do - it's another alternative data indicator that everything is going in the right direction:

3. Tyra Biosciences Inc ($TYRA) - a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle-invasive bladder cancer.

The guys were also presenting at the 2021 Jefferies London Healthcare Conference lately which caused some hype around the stock.

As always, today's top is available here: mentions on twitter&over=last week

You can easily check other alternative data points for these 4 companies (and any other US public company) just by clicking on their tickers :)

Subscribe to Contora

Don’t miss out on the latest issues. Sign up now to get access to the library of members-only issues.